Patient#	Sample#	BAD:(BAD, protein),	CSNK2A1:(CSNK2A1, protein),	Calpain-1:(Calpain-1, protein),	Caveolin-1:(Caveolin-1, protein),	ERK1-2:(ERK1-2, protein),	GRK5:(GRK5, protein),	HSP70-1:(HSP70-1, protein),	KLK6:(KLK6, protein),(response to stress, active),	MAOB:(MAOB, protein),	PARK2:(PARK2, protein),	PARK7:(PARK7, protein),	PKC delta:(PKC delta, protein),	PLD1:(PLD1, protein),	PTK2B:(PTK2B, protein),	SLC6A3:(SLC6A3, protein),	STUB1:(STUB1, protein),	SYK:(SYK, protein),	Src Family Kinases:(Src Family Kinases, protein),	TOR1A:(TOR1A, protein),	UBE2L3:(UBE2L3, protein),	FKBP1A:(FKBP1A, protein),	PLCB2:(PLCB2, protein),	SNCAIP:(PARK2, active),(SNCAIP, protein),	Src Family Kinases-active:(PTK2B, active),(Src Family Kinases, active),(Src Family Kinases-active, protein),	Alpha-Synuclein (Aggregates)	Alpha-Synuclein (Fibrillar inclusion bodies):(Alpha-Synuclein (Aggregates), active),	PKC:(Alpha-Synuclein (Aggregates), active),(PKC, protein),	PLD2:(Alpha-Synuclein (Aggregates), active),(PLD2, protein),	negative regulation of transcription:(Alpha-Synuclein (Aggregates), active),(ERK1-2, active),	positive regulation of gene-specific transcription:(Alpha-Synuclein (Aggregates), active),(Caveolin-1, active),	protein targeting to lysosome:(Alpha-Synuclein (Aggregates), active),	Alpha-Synuclein/DAT	Dopamine:(Alpha-Synuclein/DAT, active),	Alpha-Synuclein/DJ1	Alpha-Synuclein/DJ1 (aggregates):(Alpha-Synuclein/DJ1, active),	Alpha-Synuclein/HSP70-1/CHIP	Alpha-Synuclein/PLC beta 2	IP3:(Alpha-Synuclein/PLC beta 2, active),(PI-4-5-P2, active),	Alpha-Synuclein/PLD1	Alpha-Synuclein/PLD2	Alpha-Synuclein/Torsin A	Alpha-Synuclein/alpha-Tubulin/beta-Tubulin	BAD/PKC delta/Alpha-Synuclein	neuron apoptosis:(BAD/PKC delta/Alpha-Synuclein, active),(DA related ROS, active),	LEWY BODY	26S Proteasome:(LEWY BODY, active),	SNCA:(26S Proteasome, active),(Alpha-Synuclein (Fibrillar inclusion bodies), active),(CSNK2A1, active),(Calpain-1, active),(GRK5, active),(KLK6, active),(PARK2, active),(SNCA, protein),(SYK, active),(Src Family Kinases-active, active),(UBE2L3, active),(UCHL1, active),	cell death:(26S Proteasome, active),	proteasomal ubiquitin-dependent protein catabolic process:(26S Proteasome, active),	PPP2R5D:(PPP2R5D, protein),(SNCA, active),	degradation:(26S Proteasome, active),(Alpha-Synuclein/HSP70-1/CHIP, active),(DA related ROS, active),(Dopamine, active),(MAOB, active),(SNCA, active),	TH:(PPP2R5D, active),(TH, protein),	
